Rx (Prescription Medicine)
USD $ 120.00
Melphater 50mg 注射剂是一种重要的化疗药物，用于治疗多种癌症。其活性成分 Melphalan 是一种烷化剂，通过干扰癌细胞的 DNA，阻止其生长和分裂，最终导致癌细胞死亡。
Melphalan 主要用于治疗多发性骨髓瘤和卵巢癌。它也可与其他化疗药物联合使用，或作为干细胞移植前的预处理方案。
Melphater 50mg 注射剂的剂量和用法由合格的医疗专业人员根据具体的癌症类型、病情阶段以及患者的整体健康状况确定。通常通过静脉给药。
与 Melphater 50mg 注射剂相关的常见副作用可能包括恶心、呕吐、脱发以及血细胞计数下降（白细胞减少、血小板减少、贫血）。更严重的副作用也可能发生，患者应立即向医生报告任何不寻常的症状。
Melphater 50mg 注射剂应储存在室温，避光保存。务必遵循制造商及您的医疗提供者提供的具体储存说明。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Strength |
其他品牌的 Melphalan 50 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
